Responsible use of rifampin for the treatment of latent tuberculosis infection.

Responsible use of rifampin for the treatment of latent tuberculosis infection. CMAJ. 2019 Jun 24;191(25):E678-E679 Authors: Batt J, Khan K PMID: 31235488 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31235488?dopt=Abstract

Source: cmaj - June 23, 2019 Category: General Medicine Authors: Batt J, Khan K Tags: CMAJ Source Type: research

More News: General Medicine | Tuberculosis